{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:24:03Z","timestamp":1793247843278,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 31971357"],"award-info":[{"award-number":["No. 31971357"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer cachexia (CAC) reduces patient survival and quality of life. Developments of efficient therapeutic strategies are required for the CAC treatments. This long-term process could be shortened by the drug-repositioning approach which exploits old drugs approved for non-cachexia disease. Amiloride, a diuretic drug, is clinically used for treatments of hypertension and edema due to heart failure. Here, we explored the effects of the amiloride treatment for ameliorating muscle wasting in murine models of cancer cachexia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The CT26 and LLC tumor cells were subcutaneously injected into mice to induce colon cancer cachexia and lung cancer cachexia, respectively. Amiloride was intraperitoneally injected daily once tumors were formed. Cachexia features of the CT26 model and the LLC model were separately characterized by phenotypic, histopathologic and biochemical analyses. Plasma exosomes and muscle atrophy-related proteins were quantitatively analyzed. Integrative NMR-based metabolomic and transcriptomic analyses were conducted to identify significantly altered metabolic pathways and distinctly changed metabolism-related biological processes in gastrocnemius.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The CT26 and LLC cachexia models displayed prominent cachexia features including decreases in body weight, skeletal muscle, adipose tissue, and muscle strength. The amiloride treatment in tumor-bearing mice distinctly alleviated muscle atrophy and relieved cachexia-related features without affecting tumor growth. Both the CT26 and LLC cachexia mice showed increased plasma exosome densities which were largely derived from tumors. Significantly, the amiloride treatment inhibited tumor-derived exosome release, which did not obviously affect exosome secretion from non-neoplastic tissues or induce observable systemic toxicities in normal healthy mice. Integrative-omics revealed significant metabolic impairments in cachectic gastrocnemius, including promoted muscular catabolism, inhibited muscular protein synthesis, blocked glycolysis, and impeded ketone body oxidation. The amiloride treatment evidently improved the metabolic impairments in cachectic gastrocnemius.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Amiloride ameliorates cachectic muscle wasting and alleviates cancer cachexia progression through inhibiting tumor-derived exosome release. Our results are beneficial to understanding the underlying molecular mechanisms, shedding light on the potentials of amiloride in cachexia therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13395-021-00274-5","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T01:02:39Z","timestamp":1625533359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release"],"prefix":"10.1186","volume":"11","author":[{"given":"Lin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haisheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2318-2033","authenticated-orcid":false,"given":"Donghai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"issue":"5","key":"274_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489\u201395. https:\/\/doi.org\/10.1016\/S1470-2045(10)70218-7.","journal-title":"Lancet Oncol."},{"issue":"2","key":"274_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.3","volume":"5","author":"PE Porporato","year":"2016","unstructured":"Porporato PE. Understanding cachexia as a cancer metabolism syndrome. Oncogenesis. 2016;5(2):e200. https:\/\/doi.org\/10.1038\/oncsis.2016.3.","journal-title":"Oncogenesis."},{"issue":"1","key":"274_CR3","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4(1):17105. https:\/\/doi.org\/10.1038\/nrdp.2017.105.","journal-title":"Nat Rev Dis Primers."},{"issue":"7581","key":"274_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/528182a","volume":"528","author":"C Lok","year":"2015","unstructured":"Lok C. Cachexia: The last illness. Nature. 2015;528(7581):182\u20133. https:\/\/doi.org\/10.1038\/528182a.","journal-title":"Nature."},{"key":"274_CR5","unstructured":"World Health Organization. [https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/cancer]. Accessed 16 Jan 2021."},{"issue":"11","key":"274_CR6","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM, Busquets S, Stemmler B, L\u00f3pez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754\u201362. https:\/\/doi.org\/10.1038\/nrc3829.","journal-title":"Nat Rev Cancer."},{"issue":"5","key":"274_CR7","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1042\/BST20180213","volume":"46","author":"SV Chitti","year":"2018","unstructured":"Chitti SV, Fonseka P, Mathivanan S. Emerging role of extracellular vesicles in mediating cancer cachexia. Biochem Soc Trans. 2018;46(5):1129\u201336. https:\/\/doi.org\/10.1042\/BST20180213.","journal-title":"Biochem Soc Trans."},{"issue":"7","key":"274_CR8","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/gutjnl-2014-308350","volume":"65","author":"G Sagar","year":"2016","unstructured":"Sagar G, Sah RP, Javeed N, Dutta SK, Smyrk TC, Lau JS, et al. Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue. Gut. 2016;65(7):1165\u201374. https:\/\/doi.org\/10.1136\/gutjnl-2014-308350.","journal-title":"Gut."},{"issue":"1","key":"274_CR9","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41467-017-00726-x","volume":"8","author":"G Zhang","year":"2017","unstructured":"Zhang G, Liu Z, Ding H, Zhou Y, Doan HA, Sin KWT, et al. Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90. Nat Commun. 2017;8(1):589. https:\/\/doi.org\/10.1038\/s41467-017-00726-x.","journal-title":"Nat Commun."},{"issue":"1","key":"274_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s12943-018-0899-5","volume":"17","author":"Q Wu","year":"2018","unstructured":"Wu Q, Sun S, Li Z, Yang Q, Li B, Zhu S, et al. Tumour-originated exosomal miR-155 triggers cancer-associated cachexia to promote tumour progression. Mol Cancer. 2018;17(1):155. https:\/\/doi.org\/10.1186\/s12943-018-0899-5.","journal-title":"Mol Cancer."},{"issue":"4849","key":"274_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1126\/science.2451291","volume":"240","author":"CM Tang","year":"1988","unstructured":"Tang CM, Presser F, Morad M. Amiloride selectively blocks the low threshold (T) calcium channel. Science. 1988;240(4849):213\u20135. https:\/\/doi.org\/10.1126\/science.2451291.","journal-title":"Science."},{"issue":"2","key":"274_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1172\/JCI40483","volume":"120","author":"F Chalmin","year":"2010","unstructured":"Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, et al. Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest. 2010;120(2):457\u201371. https:\/\/doi.org\/10.1172\/JCI40483.","journal-title":"J Clin Invest."},{"issue":"3","key":"274_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1242\/jcs.074088","volume":"124","author":"D Fitzner","year":"2011","unstructured":"Fitzner D, Schnaars M, van Rossum D, Krishnamoorthy G, Dibaj P, Bakhti M, et al. Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis. J Cell Sci. 2011;124(3):447\u201358. https:\/\/doi.org\/10.1242\/jcs.074088.","journal-title":"J Cell Sci."},{"issue":"12","key":"274_CR14","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1073\/pnas.1402714111","volume":"111","author":"WA He","year":"2014","unstructured":"He WA, Calore F, Londhe P, Canella A, Guttridge DC, Croce CM. Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci U S A. 2014;111(12):4525\u20139. https:\/\/doi.org\/10.1073\/pnas.1402714111.","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"274_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1021\/acsnano.7b07782","volume":"12","author":"Y Tian","year":"2018","unstructured":"Tian Y, Ma L, Gong M, Su G, Zhu S, Zhang W, et al. Protein profiling and sizing of extracellular vesicles from colorectal cancer patients via flow cytometry. ACS Nano. 2018;12(1):671\u201380. https:\/\/doi.org\/10.1021\/acsnano.7b07782.","journal-title":"ACS Nano."},{"issue":"6","key":"274_CR16","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.nano.2011.04.003","volume":"7","author":"RA Dragovic","year":"2011","unstructured":"Dragovic RA, Gardiner C, Brooks AS, Tannetta DS, Ferguson DJ, Hole P, et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine. 2011;7(6):780\u20138. https:\/\/doi.org\/10.1016\/j.nano.2011.04.003.","journal-title":"Nanomedicine."},{"issue":"1","key":"274_CR17","doi-asserted-by":"publisher","first-page":"1555419","DOI":"10.1080\/20013078.2018.1555419","volume":"8","author":"LG Rikkert","year":"2019","unstructured":"Rikkert LG, Nieuwland R, Terstappen L, Coumans FAW. Quality of extracellular vesicle images by transmission electron microscopy is operator and protocol dependent. J Extracell Vesicles. 2019;8(1):1555419. https:\/\/doi.org\/10.1080\/20013078.2018.1555419.","journal-title":"J Extracell Vesicles."},{"issue":"1","key":"274_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13395-018-0188-4","volume":"9","author":"P Cui","year":"2019","unstructured":"Cui P, Shao W, Huang C, Wu CJ, Jiang B, Lin D. Metabolic derangements of skeletal muscle from a murine model of glioma cachexia. Skelet Muscle. 2019;9(1):3. https:\/\/doi.org\/10.1186\/s13395-018-0188-4.","journal-title":"Skelet Muscle."},{"issue":"4","key":"274_CR19","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1021\/acs.jproteome.9b00088","volume":"18","author":"P Cui","year":"2019","unstructured":"Cui P, Huang C, Guo J, Wang Q, Liu Z, Zhuo H, et al. Metabolic profiling of tumors, sera, and skeletal muscles from an orthotopic murine model of gastric cancer associated-cachexia. J Proteome Res. 2019;18(4):1880\u201392. https:\/\/doi.org\/10.1021\/acs.jproteome.9b00088.","journal-title":"J Proteome Res."},{"issue":"11","key":"274_CR20","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/nprot.2007.376","volume":"2","author":"O Beckonert","year":"2007","unstructured":"Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2(11):2692\u2013703. https:\/\/doi.org\/10.1038\/nprot.2007.376.","journal-title":"Nat Protoc."},{"issue":"2","key":"274_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/jcsm.12536","volume":"11","author":"S Rong","year":"2020","unstructured":"Rong S, Wang L, Peng Z, Liao Y, Li D, Yang X, et al. The mechanisms and treatments for sarcopenia: could exosomes be a perspective research strategy in the future? J Cachexia Sarcopenia Muscle. 2020;11(2):348\u201365. https:\/\/doi.org\/10.1002\/jcsm.12536.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"12","key":"274_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.trecan.2018.10.001","volume":"4","author":"SF Schmidt","year":"2018","unstructured":"Schmidt SF, Rohm M, Herzig S, Berriel DM. Cancer cachexia: more than skeletal muscle wasting. Trends Cancer. 2018;4(12):849\u201360. https:\/\/doi.org\/10.1016\/j.trecan.2018.10.001.","journal-title":"Trends Cancer."},{"issue":"12","key":"274_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.jash.2014.09.019","volume":"8","author":"CS Oxlund","year":"2014","unstructured":"Oxlund CS, Buhl KB, Jacobsen IA, Hansen MR, Gram J, Henriksen JE, et al. Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension. J Am Soc Hypertens. 2014;8(12):872\u201381. https:\/\/doi.org\/10.1016\/j.jash.2014.09.019.","journal-title":"J Am Soc Hypertens."},{"key":"274_CR24","doi-asserted-by":"publisher","unstructured":"Fuchs SC, Poli-de-Figueiredo CE, Figueiredo Neto JA, Scala LC, Whelton PK, Mosele F, et al. Effectiveness of chlorthalidone plus amiloride for the prevention of hypertension: the PREVER-prevention randomized clinical trial. J Am Heart Assoc. 2016;5(12). https:\/\/doi.org\/10.1161\/JAHA.116.004248.","DOI":"10.1161\/JAHA.116.004248"},{"key":"274_CR25","doi-asserted-by":"crossref","unstructured":"Fuchs FD, Scala LCN, Vilela-Martin JF, Whelton PK, Poli-de-Figueiredo CE, Pereira ESR, et al. Effectiveness of chlorthalidone\/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial. Acta Diabetol. 2020.","DOI":"10.1007\/s00592-020-01611-8"},{"issue":"2","key":"274_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1158\/0008-5472.CAN-10-1037","volume":"71","author":"WH Chang","year":"2011","unstructured":"Chang WH, Liu TC, Yang WK, Lee CC, Lin YH, Chen TY, et al. Amiloride modulates alternative splicing in leukemic cells and resensitizes Bcr-AblT315I mutant cells to imatinib. Cancer Res. 2011;71(2):383\u201392. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1037.","journal-title":"Cancer Res."},{"issue":"21","key":"274_CR27","doi-asserted-by":"publisher","first-page":"6602","DOI":"10.1158\/1078-0432.CCR-17-0678","volume":"23","author":"EA Rojas","year":"2017","unstructured":"Rojas EA, Corchete LA, San-Segundo L, Mart\u00ednez-Blanch JF, Codo\u00f1er FM, Pa\u00edno T, et al. Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma. Clin Cancer Res. 2017;23(21):6602\u201315. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0678.","journal-title":"Clin Cancer Res."},{"issue":"4","key":"274_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1002\/jcsm.12434","volume":"10","author":"Y Hong","year":"2019","unstructured":"Hong Y, Lee JH, Jeong KW, Choi CS, Jun HS. Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy. J Cachexia Sarcopenia Muscle. 2019;10(4):903\u201318. https:\/\/doi.org\/10.1002\/jcsm.12434.","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"274_CR29","doi-asserted-by":"crossref","unstructured":"Huang WC, Kuo KT, Bamodu OA, Lin YK, Wang CH, Lee KY, Wang LS, Yeh CT, Tsai JT. Astragalus polysaccharide (PG2) Ameliorates Cancer Symptom Clusters, as well as Improves Quality of Life in Patients with Metastatic Disease, through Modulation of the Inflammatory Cascade. Cancers (Basel). 2019, 11.","DOI":"10.20944\/preprints201906.0193.v1"},{"issue":"2","key":"274_CR30","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/jcsm.12023","volume":"6","author":"JA Chen","year":"2015","unstructured":"Chen JA, Splenser A, Guillory B, Luo J, Mendiratta M, Belinova B, et al. Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved. J Cachexia Sarcopenia Muscle. 2015;6(2):132\u201343. https:\/\/doi.org\/10.1002\/jcsm.12023.","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"274_CR31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/978-1-910315-07-1_5","volume-title":"Cancer Cachexia","author":"E Del Fabbro","year":"2012","unstructured":"Del Fabbro E, Inui A, Strasser F. Managing cancer cachexia. In: Cancer Cachexia. Tarporley: Springer Healthcare Ltd; 2012. p. 51\u201372."},{"issue":"6","key":"274_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.clnu.2010.06.003","volume":"29","author":"S Busquets","year":"2010","unstructured":"Busquets S, Serpe R, Sirisi S, Toledo M, Coutinho J, Mart\u00ednez R, et al. Megestrol acetate: its impact on muscle protein metabolism supports its use in cancer cachexia. Clin Nutr. 2010;29(6):733\u20137. https:\/\/doi.org\/10.1016\/j.clnu.2010.06.003.","journal-title":"Clin Nutr."},{"issue":"3","key":"274_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.clnu.2013.01.004","volume":"32","author":"JM Argil\u00e9s","year":"2013","unstructured":"Argil\u00e9s JM, Anguera A, Stemmler B. A new look at an old drug for the treatment of cancer cachexia: megestrol acetate. Clin Nutr. 2013;32(3):319\u201324. https:\/\/doi.org\/10.1016\/j.clnu.2013.01.004.","journal-title":"Clin Nutr."},{"issue":"4","key":"274_CR34","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou X, Wang JL, Lu J, Song Y, Kwak KS, Jiao Q, et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell. 2010;142(4):531\u201343. https:\/\/doi.org\/10.1016\/j.cell.2010.07.011.","journal-title":"Cell."},{"issue":"4","key":"274_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cell.2010.08.004","volume":"142","author":"MJ Tisdale","year":"2010","unstructured":"Tisdale MJ. Reversing cachexia. Cell. 2010;142(4):511\u20132. https:\/\/doi.org\/10.1016\/j.cell.2010.08.004.","journal-title":"Cell."},{"issue":"2","key":"274_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/jcsm.12054","volume":"7","author":"X Chen","year":"2016","unstructured":"Chen X, Wu Y, Yang T, Wei M, Wang Y, Deng X, et al. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. J Cachexia Sarcopenia Muscle. 2016;7(2):225\u201332. https:\/\/doi.org\/10.1002\/jcsm.12054.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"1","key":"274_CR37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/jcsm.12497","volume":"11","author":"WW Cheung","year":"2020","unstructured":"Cheung WW, Hao S, Wang Z, Ding W, Zheng R, Gonzalez A, et al. Vitamin D repletion ameliorates adipose tissue browning and muscle wasting in infantile nephropathic cystinosis-associated cachexia. J Cachexia Sarcopenia Muscle. 2020;11(1):120\u201334. https:\/\/doi.org\/10.1002\/jcsm.12497.","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"16","key":"274_CR38","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1042\/BCJ20170032","volume":"474","author":"JM Argil\u00e9s","year":"2017","unstructured":"Argil\u00e9s JM, L\u00f3pez-Soriano FJ, Stemmler B, Busquets S. Novel targeted therapies for cancer cachexia. Biochem J. 2017;474(16):2663\u201378. https:\/\/doi.org\/10.1042\/BCJ20170032.","journal-title":"Biochem J."},{"issue":"8","key":"274_CR39","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1097\/HJH.0000000000000967","volume":"34","author":"H Andersen","year":"2016","unstructured":"Andersen H, Hansen PB, Bistrup C, Nielsen F, Henriksen JE, Jensen BL. Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy. J Hypertens. 2016;34(8):1621\u20139. https:\/\/doi.org\/10.1097\/HJH.0000000000000967.","journal-title":"J Hypertens."},{"issue":"3","key":"274_CR40","first-page":"1074","volume":"43","author":"IL Cameron","year":"1983","unstructured":"Cameron IL, Hunter KE. Effect of cancer cachexia and amiloride treatment on the intracellular sodium content in tissue cells. Cancer Res. 1983;43(3):1074\u20138.","journal-title":"Cancer Res."},{"issue":"3","key":"274_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.onc.1208213","volume":"24","author":"KM Kim","year":"2005","unstructured":"Kim KM, Lee YJ. Amiloride augments TRAIL-induced apoptotic death by inhibiting phosphorylation of kinases and phosphatases associated with the P13K-Akt pathway. Oncogene. 2005;24(3):355\u201366. https:\/\/doi.org\/10.1038\/sj.onc.1208213.","journal-title":"Oncogene."},{"key":"274_CR42","doi-asserted-by":"crossref","unstructured":"Harguindey S, Pedraz JL, Garc\u00eda Ca\u00f1ero R, P\u00e9rez de Diego J, Cragoe EJ, Jr. Hydrogen ion-dependent oncogenesis and parallel new avenues to cancer prevention and treatment using a H(+)-mediated unifying approach: pH-related and pH-unrelated mechanisms. Crit Rev Oncog. 1995, 6:1-33.","DOI":"10.1615\/CritRevOncog.v6.i1.20"},{"key":"274_CR43","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3389\/fphar.2020.00848","volume":"11","author":"J Iorio","year":"2020","unstructured":"Iorio J, Duranti C, Lottini T, Lastraioli E, Bagni G, Becchetti A, et al. K(V)11.1 Potassium channel and the Na(+)\/H(+) antiporter NHE1 modulate adhesion-dependent intracellular pH in colorectal cancer cells. Front Pharmacol. 2020;11:848.","journal-title":"Front Pharmacol"},{"issue":"9","key":"274_CR44","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1089\/dna.2013.1998","volume":"32","author":"JY Tang","year":"2013","unstructured":"Tang JY, Chang HW, Chang JG. Modulating roles of amiloride in irradiation-induced antiproliferative effects in glioblastoma multiforme cells involving Akt phosphorylation and the alternative splicing of apoptotic genes. DNA Cell Biol. 2013;32(9):504\u201310. https:\/\/doi.org\/10.1089\/dna.2013.1998.","journal-title":"DNA Cell Biol."},{"issue":"22","key":"274_CR45","doi-asserted-by":"publisher","first-page":"20083","DOI":"10.1074\/jbc.M301642200","volume":"278","author":"A Savina","year":"2003","unstructured":"Savina A, Furl\u00e1n M, Vidal M, Colombo MI. Exosome release is regulated by a calcium-dependent mechanism in K562 cells. J Biol Chem. 2003;278(22):20083\u201390. https:\/\/doi.org\/10.1074\/jbc.M301642200.","journal-title":"J Biol Chem."},{"issue":"5","key":"274_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.tem.2016.03.002","volume":"27","author":"J Zhou","year":"2016","unstructured":"Zhou J, Liu B, Liang C, Li Y, Song YH. Cytokine signaling in skeletal muscle wasting. Trends Endocrinol Metab. 2016;27(5):335\u201347. https:\/\/doi.org\/10.1016\/j.tem.2016.03.002.","journal-title":"Trends Endocrinol Metab."},{"issue":"1","key":"274_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41574-018-0123-0","volume":"15","author":"JM Argil\u00e9s","year":"2019","unstructured":"Argil\u00e9s JM, Stemmler B, L\u00f3pez-Soriano FJ, Busquets S. Inter-tissue communication in cancer cachexia. Nature Reviews Endocrinology. 2019;15(1):9\u201320. https:\/\/doi.org\/10.1038\/s41574-018-0123-0.","journal-title":"Nature Reviews Endocrinology."},{"key":"274_CR48","doi-asserted-by":"crossref","unstructured":"Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, Liu M, Xu C, Zhang Q, Zhu H, et al. ZIP4 promotes muscle wasting and cachexia in mice with orthotopic pancreatic tumors by stimulating RAB27B-regulated release of extracellular vesicles from cancer cells Gastroenterology. 2019, 156:722-734.e726.","DOI":"10.1053\/j.gastro.2018.10.026"},{"issue":"1","key":"274_CR49","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.bbrc.2018.09.139","volume":"506","author":"W Hu","year":"2018","unstructured":"Hu W, Ru Z, Xiao W, Xiong Z, Wang C, Yuan C, et al. Adipose tissue browning in cancer-associated cachexia can be attenuated by inhibition of exosome generation. Biochem Biophys Res Commun. 2018;506(1):122\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.139.","journal-title":"Biochem Biophys Res Commun."},{"key":"274_CR50","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","volume":"319","author":"K Trajkovic","year":"2008","unstructured":"Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, et al. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008;319:1244\u20137.","journal-title":"Science"},{"issue":"43","key":"274_CR51","doi-asserted-by":"publisher","first-page":"41128","DOI":"10.1074\/jbc.M206747200","volume":"277","author":"C Luberto","year":"2002","unstructured":"Luberto C, Hassler DF, Signorelli P, Okamoto Y, Sawai H, Boros E, et al. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase. J Biol Chem. 2002;277(43):41128\u201339. https:\/\/doi.org\/10.1074\/jbc.M206747200.","journal-title":"J Biol Chem."},{"issue":"5","key":"274_CR52","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1600-0854.2010.01041.x","volume":"11","author":"D Feng","year":"2010","unstructured":"Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, et al. Cellular internalization of exosomes occurs through phagocytosis. Traffic. 2010;11(5):675\u201387. https:\/\/doi.org\/10.1111\/j.1600-0854.2010.01041.x.","journal-title":"Traffic."},{"issue":"24","key":"274_CR53","doi-asserted-by":"publisher","first-page":"17713","DOI":"10.1074\/jbc.M112.445403","volume":"288","author":"KJ Svensson","year":"2013","unstructured":"Svensson KJ, Christianson HC, Wittrup A, Bourseau-Guilmain E, Lindqvist E, Svensson LM, et al. Exosome uptake depends on ERK1\/2-heat shock protein 27 signaling and lipid Raft-mediated endocytosis negatively regulated by caveolin-1. J Biol Chem. 2013;288(24):17713\u201324. https:\/\/doi.org\/10.1074\/jbc.M112.445403.","journal-title":"J Biol Chem."},{"key":"274_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bcp.2019.02.025","volume":"164","author":"GM Sanvee","year":"2019","unstructured":"Sanvee GM, Panajatovic MV, Bouitbir J, Kr\u00e4henb\u00fchl S. Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle. Biochem Pharmacol. 2019;164:23\u201333. https:\/\/doi.org\/10.1016\/j.bcp.2019.02.025.","journal-title":"Biochem Pharmacol."},{"issue":"4","key":"274_CR55","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1016\/j.ijcard.2013.04.150","volume":"168","author":"S Palus","year":"2013","unstructured":"Palus S, von Haehling S, Flach VC, Tschirner A, Doehner W, Anker SD, et al. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia. Int J Cardiol. 2013;168(4):3412\u20138. https:\/\/doi.org\/10.1016\/j.ijcard.2013.04.150.","journal-title":"Int J Cardiol."},{"key":"274_CR56","doi-asserted-by":"crossref","unstructured":"Koutnik AP, Poff AM, Ward NP, DeBlasi JM, Soliven MA, Romero MA, Roberson PA, Fox CD, Roberts MD, D'Agostino DP. Ketone bodies attenuate wasting in models of atrophy. J Cachexia Sarcopenia Muscle. 2020.","DOI":"10.1002\/jcsm.12554"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-021-00274-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13395-021-00274-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-021-00274-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T12:52:19Z","timestamp":1699188739000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-021-00274-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1186\/s13395-021-00274-5","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]},"assertion":[{"value":"17 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were performed in Xiamen University Laboratory Animal Center, according to protocols approved by the Institutional Animal Care and Use Committee of Xiamen University. The study protocol of collecting blood samples of cancer patients was approved by the Ethics Committee of Affiliated Zhongshan Hospital of Xiamen University, China. Patients with colorectal cancer, lung cancer, and gastric cancer were enrolled, which were informed and wrote the consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}